Delivery Order SPE2DB22D2211-SPE2DB25FSEPN
- Not listed
- The Defense Logistics Agency awarded a $1,861.34 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Briviact 25 mg tablets (60-count units). This is a firm fixed price, non-set-aside contract with a completion date of September 4, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Briviact 100 mg tablets (60-count packages) with a ceiling value of $1,067.55. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a $1,044.28 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $1,859.98 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Briviact 50 mg tablets (60-count packages). This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The order is scheduled for completion by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,804.93 to AmerisourceBergen Drug Corp for 60 tablets of Briviact 50 mg on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $10,974.69 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,733.90 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60 count) on September 10, 2025, with a completion date of September 11, 2025. This firm fixed-price, competitively awarded contract represents a single-line delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,755.15 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The order will be...
- The Defense Logistics Agency awarded a delivery order valued at $1,135.62 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Briviact 50 mg tablets (60-count packaging). This is a firm fixed price delivery order with no set-aside designation, executed under competitive procedures. The contract specifies a place of performance in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters. The order carries an ultimate completion date of September...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSEPNDelivery Order
The Defense Logistics Agency awarded a $5,572.14 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Briviact 100 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 10, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company maintains a comprehensive portfolio of pharmaceutical products and medical supplies distributed through the DLA Medical Supply Chain. As a competitively awarded contractor, AmerisourceBergen demonstrates consistent capability in fulfilling diverse federal medical supply requirements, ranging from small-value transactions to substantial orders exceeding $45,000, with delivery orders utilizing firm fixed pricing structures. This delivery order for Briviact, an antiepileptic medication, exemplifies the company's role in supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/9/25 |